The Blurring Line Between Semi And Bio

Law360, New York (May 14, 2012, 1:27 PM EDT) -- At the last two nanotechnology-focused events I have attended, a common topic of discussion has arisen. People in the industry are noticing that the line that has typically, and clearly, divided semiconductor technology and biotechnology, is now beginning to blur. IP practitioners need to realize that this new semi/bio combination is highly technically complex and that they may need to improve their skills or work with others who have this skill set in order to be effective in this challenging field. Whether it be in the...
To view the full article, register now.